The Role of Pediatric Andrology Prevention in Reducing Adult Male Infertility
Journal of Pediatric Advance Research · 2026
DOI: 10.46889/jpar.2026.5302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Advance Research, 2026. Verfasst von Nicola Zampieri und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
The future of male pediatric fertility preservation is poised for transformative progress. Over the past fifteen years, the world has witnessed a notable decline in birth rates, a phenomenon often referred to as global low fertility or denatality. While social and economic determinants play a significant role, biological factors, particularly male infertility, have emerged as an increasingly recognized contributor to declining birth rates. Male infertility affects approximately 7-12% of men globally and is implicated in nearly 40-50% of all couples experiencing difficulties in conceiving. For this reason the role of pediatric andrology is essential to reduce adult male infertility. Emerging techniques such as testicular tissue cryopreservation, in-vitro spermatogenesis and stem cell-based therapies offer hope for restoring reproductive potential in boys who otherwise face irreversible infertility. Achieving this potential will require a combination of scientific innovation, ethical guidance and clinical integration.
Zitieren
APA
Zampieri, N., & Dando, I. (2026). The Role of Pediatric Andrology Prevention in Reducing Adult Male Infertility. Journal of Pediatric Advance Research. https://doi.org/10.46889/jpar.2026.5302
Vancouver
Zampieri N, Dando I. The Role of Pediatric Andrology Prevention in Reducing Adult Male Infertility. Journal of Pediatric Advance Research. 2026. doi:10.46889/jpar.2026.5302
BibTeX
@article{Zampieri2026,
author = {Zampieri, Nicola and Dando, Ilaria},
title = {The Role of Pediatric Andrology Prevention in Reducing Adult Male Infertility},
journal = {Journal of Pediatric Advance Research},
year = {2026},
doi = {10.46889/jpar.2026.5302}
}
EUVIMED